Blinding in a clinical trial primarily helps to reduce:

Correct answer: Performance and detection bias

Blinding keeps participants, clinicians, and outcome assessors unaware of group assignment. That reduces performance bias (differences in care or behaviour between arms) and detection bias (differences in how outcomes are measured), improving the internal validity of the trial. Selection bias is addressed instead by randomization and allocation concealment.